Synopsis of recent research by authors named "Huiting Liang"
- Huiting Liang's recent research focuses on developing innovative approaches for personalized cancer immunotherapy and therapeutic targeting methods, including a peptide-based nano-vaccine and covalent proteolysis-targeting chimeras (PROTACs) that enhance selectivity and efficacy against challenging proteins.
- Key findings include the successful construction of a sulfonium-stapled peptide delivery system that improves neoantigen vaccine effectiveness and insights into the role of PHLDB2 in regulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma, which correlates with patient prognosis.
- Liang also explored the macroscale superlubricity achieved through nanoscale engineering of graphene structures, emphasizing practical applications, and conducted epidemiological studies on the prevalence of major depressive symptoms among adults with arthritis and thyroid cancer trends in Guangzhou, China.
